Epstein-Barr virus: NIH launches early-stage clinical trial to evaluate investigational preventative vaccine
by Press Release from Outbreak News Today on (#5Z00D)
NewsDesk @bactiman63 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV). EBV is the primary cause of infectious mononucleosis and is associated with certain cancers and autoimmune diseases. The Phase 1 study, which [...]
The post Epstein-Barr virus: NIH launches early-stage clinical trial to evaluate investigational preventative vaccine appeared first on Outbreak News Today.